CanSino Biologics Inc Class H CASBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.86
- Day Range
- $2.10–2.10
- 52-Week Range
- $1.86–5.01
- Bid/Ask
- $2.20 / $2.55
- Market Cap
- $519.64 Mil
- Volume/Avg
- 116 / 2,835
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,494
- Website
- https://www.cansinotech.com
Comparables
Valuation
|
Metric
|
CASBF
|
300142
|
06660
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 45.31 | 34.05 |
Price/Book Value | 0.70 | 2.55 | 2.53 |
Price/Sales | 10.62 | 6.12 | 7.72 |
Price/Cash Flow | — | 27.79 | — |
Price/Earnings
CASBF
300142
06660
Financial Strength
|
Metric
|
CASBF
|
300142
|
06660
|
|---|---|---|---|
Quick Ratio | 2.03 | 2.46 | 0.74 |
Current Ratio | 2.24 | 2.85 | 0.95 |
Interest Coverage | −33.97 | 47.19 | −51.05 |
Quick Ratio
CASBF
300142
06660
Profitability
|
Metric
|
CASBF
|
300142
|
06660
|
|---|---|---|---|
Return on Assets (Normalized) | −10.29% | 3.37% | −3.57% |
Return on Equity (Normalized) | −17.50% | 5.57% | −6.57% |
Return on Invested Capital (Normalized) | −12.58% | 3.91% | −4.09% |
Return on Assets
CASBF
300142
06660
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bqkhjbhkg | Hpl | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Gdvzkjhs | Pvfyx | $70.8 Bil | |
HLN
| Haleon PLC ADR | Vfnltnkz | Wylp | $38.2 Bil | |
VTRS
| Viatris Inc | Xhysfpfn | Cgwdx | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Krzmnzdbc | Wdzx | $12.5 Bil | |
CTLT
| Catalent Inc | Rrqtqdyrn | Pmhtrl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ysqgymhcq | Fxmk | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Rmyckgmp | Smcdz | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rpmtxvft | Smgmszq | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Mbsqgyxryw | Grqp | $2.9 Bil |